Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pulmonary Tuberculosis V01:28

Pulmonary Tuberculosis V

246
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
246
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

1.1K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.1K
Gene Regulation in Microbial Communities: Quorum Sensing01:28

Gene Regulation in Microbial Communities: Quorum Sensing

97
Quorum sensing is a mechanism of bacterial communication that enables coordinated gene expression in response to changes in population density. This facilitates collective behaviors that enhance survival, resource acquisition, and ecological adaptation. This process relies on small signaling molecules called autoinducers that accumulate as bacterial populations grow. When a critical threshold concentration of autoinducers is reached, bacterial cells collectively modify gene expression,...
97

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mucoid Pseudomonas aeruginosa-derived alginate modulates innate immune transcriptional responses and promotes intracellular growth of Mycobacterium tuberculosis and non-tuberculous mycobacteria.

Microbial pathogenesis·2026
Same author

Progranulin as a context-dependent regulator of innate immunity in bacterial infections.

Cytokine·2026
Same author

Antimicrobial proteins and peptides in pregnancy: Guardians of the maternal-fetal frontier.

Frontiers in immunology·2026
Same author

Multi-species Microbial Modulation of the RANK/RANKL (Receptor Activator of Nuclear Factor κB/Receptor Activator of Nuclear Factor κB Ligand) Pathway Induces Osteoclastogenic Priming in Apical Periodontitis.

Cureus·2026
Same author

Detection of drug resistance mutations and spoligotype mapping in Mycobacterium tuberculosis using deeplex sequencing, including novel and uncharacterized spoligotypes.

Archives of microbiology·2026
Same author

Human β-defensin-3 as a transcriptional convergence point linking innate immunity, endocrine signals, and tissue repair.

Peptides·2026

Related Experiment Video

Updated: Sep 17, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.0K

Tuberculosis drug development; fluoroquinolone structural tailoring.

Alicia M Gutiérrez-Mauricio1,2, Juan Valentín Trujillo-Paez3, Luis Alberto Trejo-Martinez4

  • 1Unidad Académica de Ciencias Químicas, Universidad Autónoma de Zacatecas, Zacatecas, Mexico.

The Journal of Antibiotics
|July 2, 2025
PubMed
Summary

New fluoroquinolone (FQ) drugs show promise in combating multidrug-resistant tuberculosis (TB). Research focuses on novel synthetic FQ molecules to address the global challenge of Mycobacterium tuberculosis resistance.

More Related Videos

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.5K

Related Experiment Videos

Last Updated: Sep 17, 2025

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis
10:29

A High-throughput Compatible Assay to Evaluate Drug Efficacy against Macrophage Passaged Mycobacterium tuberculosis

Published on: March 24, 2017

8.0K
Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments
07:50

Author Spotlight: Scalable Drug Screening Protocol for Efficient Discovery of M. abscessus Treatments

Published on: October 25, 2024

2.0K
Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence
10:06

Imaging Mycobacterium tuberculosis in Mice with Reporter Enzyme Fluorescence

Published on: February 26, 2018

7.5K

Area of Science:

  • Microbiology
  • Pharmacology
  • Infectious Diseases

Background:

  • Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), remains a leading cause of infectious disease mortality worldwide.
  • The emergence of multidrug-resistant Mtb strains necessitates the development of novel therapeutic strategies.
  • Fluoroquinolones (FQ) are broad-spectrum antibiotics crucial for treating drug-resistant TB.

Purpose of the Study:

  • To review the latest advancements in the synthesis and antitubercular activity of novel fluoroquinolone (FQ) molecules.
  • To highlight the impact of structural modifications on FQ efficacy against multidrug-resistant tuberculosis (MDR-TB).

Main Methods:

  • Literature review of recent studies on fluoroquinolone synthesis and antitubercular activity.
  • Analysis of structural modifications aimed at enhancing FQ potency and overcoming resistance mechanisms.
  • Evaluation of FQ efficacy against various strains of Mycobacterium tuberculosis, including multidrug-resistant isolates.

Main Results:

  • Several newly synthesized FQ derivatives exhibit significant in vitro activity against Mtb.
  • Structural modifications have led to improved pharmacokinetic properties, such as enhanced tissue penetration and reduced toxicity.
  • Emerging FQ generations demonstrate potential in overcoming existing resistance patterns in Mtb.

Conclusions:

  • Novel fluoroquinolones represent a promising avenue for the development of new treatments against multidrug-resistant tuberculosis.
  • Continued research into synthetic modifications of FQ is essential for addressing the global TB epidemic.
  • These advancements offer hope for more effective management of challenging TB cases.